Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events
Husain M, Bain SC, Mann J, Nauck M, Poulter N, Baeres FMM, Goldman B, Thomsen AB, Marso S (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: 490-490
Conference Proceedings Title: EUROPEAN HEART JOURNAL
Event location: Munich, GERMANY
DOI: 10.1093/eurheartj/ehy565.p2518
Involved external institutions
Toronto General Hospital (TGH)
Canada (CA)
Swansea University
United Kingdom (GB)
Novo Nordisk A/S
Denmark (DK)
Imperial College London / The Imperial College of Science, Technology and Medicine
United Kingdom (GB)
Ruhr-Universität Bochum (RUB)
Germany (DE)
Canada (CA)
Swansea University
United Kingdom (GB)
Novo Nordisk A/S
Denmark (DK)
Imperial College London / The Imperial College of Science, Technology and Medicine
United Kingdom (GB)
Ruhr-Universität Bochum (RUB)
Germany (DE)
How to cite
APA:
Husain, M., Bain, S.C., Mann, J., Nauck, M., Poulter, N., Baeres, F.M.M.,... Marso, S. (2018). Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events. In EUROPEAN HEART JOURNAL (pp. 490-490). Munich, GERMANY: OXFORD: OXFORD UNIV PRESS.
MLA:
Husain, M., et al. "Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events." Proceedings of the European-Society-of-Cardiology Congress, Munich, GERMANY OXFORD: OXFORD UNIV PRESS, 2018. 490-490.
BibTeX: Download